Neutralising antibodies against interferon beta in multiple sclerosis
- PMID: 14726180
- DOI: 10.1016/S0140-6736(03)15277-4
Neutralising antibodies against interferon beta in multiple sclerosis
Comment on
-
Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis.Lancet. 2003 Oct 11;362(9391):1184-91. doi: 10.1016/S0140-6736(03)14541-2. Lancet. 2003. PMID: 14568740 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
